India Russia covid-19 vaccine Coronavirus India Russia

Sputnik V set to become third COVID-19 vaccine in India. 91.6% efficacy to side-effects — key details

Reading now: 429
www.livemint.com

Sputnik V, another vaccine against novel coronavirus got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA) in India, according to sources, mentioned news agency PTI.

Once approved, this will be the third COVID-19 vaccine in the country.The COVID-19 vaccine was developed by Gamaleya Research Institute and the Russian defence ministry.

COVID-19 vaccine offers lasting immunity from the virus, according to Russia health ministry. Named after named after the Soviet-era satellite, Sputnik V was approved in Russia in August 2020.The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy's in September 2020 to conduct clinical trials of Sputnik V in India.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA